Richard Steinhart - 01 Aug 2025 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role: Chief Financial Officer
Signature: /s/ Richard I. Steinhart
Issuer symbol: BTAI
Transactions as of: 01 Aug 2025
Net transactions value: $0
Form type: 4
Filing time: 05 Aug 2025, 20:02:09 UTC
Previous filing: 22 Jul 2025
Next filing: 16 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Steinhart Richard I	Chief Financial Officer	C/O BIOXCEL THERAPEUTICS, INC., 555 LONG WHARF DRIVE, 12TH FLOOR, NEW HAVEN	/s/ Richard I. Steinhart	05 Aug 2025	0001293789

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTAI	Restricted Stock Units	Award	$0	+9,000		$0.000000	9,000	01 Aug 2025	Common Stock	9,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	On August 1, 2025 (the "Grant Date"), the Reporting Person was granted 9,000 RSUs, vesting as to 100% on or within thirty (30) days of 9 months from the Grant Date, subject to the Reporting Person's continued employment with the Issuer or a subsidiary of the Issuer on such date.